Back to search
FDAFDA · Food and drugs·Recall number D-0131-2023

Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05

Published January 25, 2023 · Recall initiated: November 29, 2022

Summary

FDA records drug Class I recall D-0131-2023, published January 25, 2023 and initiated November 29, 2022. Recalling firm: Accord Healthcare, Inc.; Status: Terminated; Reported quantity: Unknown; Lot: Lot: R2200232 Exp. 01/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Accord Healthcare, Inc.
Distributor
Nationwide within the United States
Lot
Lot: R2200232 Exp. 01/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05 recalled?

Yes. FDA published recall D-0131-2023 on January 25, 2023. Reported hazard: Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial

What should I do if I have this product?

Voluntary: Firm initiated · Letter